# Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

> **NCT00014456** · PHASE1 · COMPLETED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 35 (actual)

## Conditions studied

- Bladder Cancer
- Breast Cancer
- Carcinoma of Unknown Primary
- Esophageal Cancer
- Gastric Cancer
- Head and Neck Cancer
- Lung Cancer
- Melanoma (Skin)
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- Sarcoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** docetaxel
- **DRUG:** gemcitabine hydrochloride

## Key facts

- **NCT ID:** NCT00014456
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2013-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00014456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00014456, "Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00014456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*